Navigation Links
Challenging times for FDA and drug companies equals IT opportunities

Even before the intense scrutiny that started in September when Vioxxs manufacturer removed the drug from the market due to safety concerns, the U.S. Food and Drug Administration and the pharmaceutical industry faced a bumpy road.

One of the biggest challenges has been the pipeline problem, the slowdown instead of the expected acceleration in innovative m......

Full article >>> ing simulation software to improve clinical trial design and predict outcomes.

Better imaging technologies, such as for measuring drug absorption and distribution, may provide powerful insights into the biological effects of pharmaceuticals. But such tools need to be specifically developed and evaluated for drug development. These are but two examples.

Assessing Drug Safety<......

Full article >>> s accepting and investing in bar code technology at a faster rate. Demand for multi-faceted IT systems that improve both productivity and patient safety and well-being will only increase. Facilities already using bar coding will look for enhancements to these systems, and those considering whether and how to adopt bar coding will be evaluating their overall IT needs and options.


Full article >>>
'"/> By Patricia Kaeding 06/13/05

Related biology technology :

1. Sometimes, features can make a company
2. Venture-backed companies drive job creation, even in tough times
3. A disgusting video: U.S. companies sell out Americans
4. Pre-eminent, web-based companies owe success to corporate venturing
5. Visions: IT exec says CIOs must be ready to help companies ramp up trade
6. Patent licensing: For enforcing companies, the rules have changed
7. Madison firm provides $200K in capital to tech companies
8. Gala Biotech among companies sold for $3.3 billion
9. 2006: A mixed blessing for Midwest life science companies
10. Weather information companies launch data product
11. New firm to help companies land federal dollars
Post Your Comments:

(Date:12/1/2015)... Dec. 1, 2015  Symic, a clinical-stage biotherapeutics company ... matrix (ECM), today announced that it has secured $25 ... company,s pipeline, including its lead candidates SB-030 and SB-061. ... the participation by all existing major investors, as well ... total capital raised by Symic to over $43 million ...
(Date:12/1/2015)... ... ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined Texas Fertility Center as its ... procedures as well as continue his research efforts into the emerging technologies of embryo ... Zealand to bring home a High Complexity Clinical Laboratory Director named Tex,” says ...
(Date:11/30/2015)... ... , ... Global Stem Cells Group today announced ... Marriott. The Global Stem Cells Group GMP facility is equipped with the most ... researchers and practitioners, experienced in administering stem cell protocols using highly manipulated cells. ...
(Date:11/30/2015)... Partnership includes an MPP ... the u niversity , s Solid Drug Nanoparticle ... cale - up through cost ... , where licensees based anywhere in the world will have the right to ... Africa , where licensees based anywhere in the world will have the ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/9/2015)... 09, 2015 ... the "Global Law Enforcement Biometrics Market ... --> ) has announced the ... Biometrics Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):